← Scroll for more →
Cronos Group Inc. (CRON)
Medicinal Chemicals & Botanical Products
Latest Price
$3.36
TTM P/E
17.68
Normalized P/E
--
TTM Div Yield
--
Fwd Div Yield
--
Book Value
2.86
P/B Ratio
1.17
Valuation metrics
adjust assumptions →Base FCF: $3M (median of recent 5yr)
Growth: -15%/yr (median YOY, capped at 25%)
Discount rate: 10%
Terminal growth: 3%
Projection horizon: 10 years
DCF Fair Value
$2.22
34% downside
Institutional Ownership
10.6% held by institutions| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| D. E. Shaw & Co., Inc. | 8.84M | $24.0M | 2.38% | +1.22M | 2026-06-30 |
| Tidal Investments LLC | 3.77M | $10.0M | 1.02% | -259.0K | 2026-06-30 |
| Dimensional Fund Advisors LP | 3.05M | $8.0M | 0.82% | +369.2K | 2026-06-30 |
| Arrowstreet Capital, Limited Partnership | 1.99M | $5.0M | 0.54% | +113.9K | 2026-06-30 |
| Renaissance Technologies LLC | 1.74M | $4.0M | 0.47% | -267.4K | 2026-06-30 |
| Mackenzie Financial Corp | 1.60M | $6.0M | 0.43% | +868.8K | 2026-06-30 |
| CIBC World Market Inc. | 1.38M | $3.0M | 0.37% | +36.5K | 2026-06-30 |
| Citadel Advisors LLC | 1.28M | $3.0M | 0.34% | +422.6K | 2026-06-30 |
| MMCAP International Inc. SPC | 999.5K | $2.0M | 0.27% | -- | 2026-06-30 |
| Quinn Opportunity Partners LLC | 969.0K | $2.0M | 0.26% | -- | 2026-06-30 |